[AVDL] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 43.70%
YoY- -80.06%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 41,504 27,178 19,453 7,014 1,496 0 0 -
PBT -14,331 -27,249 -28,886 -36,185 -64,342 -31,364 -27,365 -35.05%
Tax -509 93 -100 89 90 -580 85 -
NP -13,822 -27,342 -28,786 -36,274 -64,432 -30,784 -27,450 -36.73%
Tax Rate - - - - - - - -
Total Cost 55,326 54,520 48,239 43,288 65,928 30,784 27,450 59.62%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -33.30 -100.60 -147.98 -517.17 -4,306.95 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.14 -0.30 -0.30 -0.41 -0.83 -0.48 -0.43 -52.70%
EPS Diluted -0.14 -0.30 -0.30 -0.41 -0.83 -0.48 -0.43 -52.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.